2025-03-05 Dingdong (Cayman) Limited HaiPress
SHANGHAI,March 3,2025 -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL),a leading fresh grocery e-commerce company in China,with advanced supply chain capabilities,today announced that it will report its unaudited financial results for the fourth quarter ended December 31,2024,before U.S. markets open on March 6,2025.
The Company will hold an earnings conference call at 7:00 A.M. Eastern Time on Thursday,March 6,2025 (8:00 P.M. Beijing Time on the same day) to discuss its financial results. Management's prepared remarks and the question-and-answer session will be conducted in English and Mandarin. Dial-in details for the earnings conference call are as follows:
International:
1-412-317-6061
United States Toll Free:
1-888-317-6003
Mainland China Toll Free:
4001-206115
Hong Kong Toll Free:
800-963976
Conference ID:
4474666
The replay will be accessible through March 13,2025 by dialing the following numbers:
International:
1-412-317-0088
United States:
1-877-344-7529
Access Code:
7865911
A live and archived webcast of the conference call will also be available at the Company's investor relations website at https://ir.100.me.
About Dingdong (Cayman) Limited
Dingdong is the leading fresh grocery e-commerce company in mainland China,with sustainable long-term growth. The Company directly provides users and households with fresh groceries,prepared food,and other food products through delivering a convenient and excellent shopping experience supported by an extensive self-operated frontline fulfillment grid. Leveraging its deep insights into consumers' evolving needs and its strong food innovation capabilities,Dingdong has successfully launched a series of private label products spanning a variety of food categories. Many of Dingdong's private label products are produced at its own production plants,allowing it to more efficiently produce and offer safe and high-quality food products. Dingdong aims to be the first choice for fresh and food shopping.
For more information,please visit: https://ir.100.me.
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM
©copyright 2009-2020 Singapore Info Map